Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib slightly increased cholesterol levels in alopecia areata patients, but these changes were manageable.

PCOS is linked to inflammation, and certain markers could help in its treatment.

Certain genetic variants increase the risk of resistance to hormone therapy in prostate cancer patients.

Improving mitochondrial health may better treat atherosclerosis than antioxidants.

Men with advanced liver disease and high oestrone and low testosterone levels have worse health outcomes.

People with androgenetic alopecia, both men and women, are more likely to develop heart diseases in the future.

Women with PCOS are more likely to have fatty liver disease, especially if they have metabolic problems.

ADT-G may be a useful indicator of increased androgen levels in women with acne and can be lowered with certain birth control pills.

People with early onset androgenetic alopecia may have a higher chance of metabolic syndrome, especially dyslipidemia.

Low SHBG and high FAI, FT, and DHEAS levels are effective in identifying PCOS.

Many young Egyptian women with PCOS also have fatty liver disease, especially if they are overweight and insulin resistant.

PCOS women have more arm fat and higher insulin resistance and glucose levels than non-PCOS women.

SHBG binding properties are unchanged in male liver cirrhosis patients.

High afamin levels are linked to metabolic syndrome and may predict its development in women with insulin resistance.

Lipedematous scalp may have a genetic link and could be associated with psychiatric conditions.

Two women with very high androgen levels had only slight skin issues, one due to a non-classical adrenal disorder and the other due to an adrenal tumor.

Lipocalin-Type Prostaglandin D2 Synthase (L-PGDS) is a protein that plays many roles in the body, including sleep regulation, pain management, food intake, and protection against harmful substances. It also affects fat metabolism, glucose intolerance, cell maturation, and is involved in various diseases like diabetes, cancer, and arthritis. It can influence sex organ development and embryonic cell differentiation, and its levels can be used as a diagnostic marker for certain conditions.

People with alopecia areata have higher levels of a heart disease marker in their blood.

Men with hormonal imbalances similar to PCOS may have increased risk of metabolic and heart diseases.

Women with PCOS have higher androgen levels that decrease with age but are still higher than in women without PCOS.

Hair growth stages don't significantly change lipid content in mouse skin.

Women with PCOS are more likely to have fatty liver disease and worse metabolic health.

People with androgenetic alopecia may have a higher risk of heart problems compared to those with alopecia areata or healthy individuals.

Statins can reduce androgen levels and improve symptoms in women with PCOS.

Women with hair loss may have higher heart disease risk.

Some blood donors on teratogenic drugs may have unsafe drug levels, suggesting a need for better deferral policies.

Certain health factors can worsen fertility treatment results in women with PCOS.

Orlistat helped reduce weight and testosterone in obese women with PCOS but did not significantly affect other androgens or cholesterol levels.

Certain blood metabolites are linked to female pattern hair loss, with some increasing risk and others offering protection.

Lower 2D:4D finger ratios in HS patients suggest prenatal hormone influence on the disease.